Staining with antibodies recognizing S-100 (a protein commonly used as a diagnostic and prognostic marker of glioma) and CD8 (glycoprotein expressed by cytotoxic T lymphocytes) was also performed (Figure 4). The gene discussed is CD8A; the disease is central nervous system cancer.